Fri, November 4, 2022
Thu, November 3, 2022
Wed, November 2, 2022

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $34 on, Nov 3rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-34-on-nov-3rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $38 to $34 on, Nov 3rd, 2022.

Matthew has made no other calls on AVNS in the last 4 months.



There are 2 other peers that have a rating on AVNS. Out of the 2 peers that are also analyzing AVNS, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $28 on, Monday, July 18th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Drew Ranieri of "Morgan Stanley" Maintained at Sell with Decreased Target to $24 on, Tuesday, October 11th, 2022

Publication Contributing Sources